Navigation Links
Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
Date:10/31/2012

mellem UCI og ITT", sagde professor Piomelli. "Vores samarbejde med at udvikle behandlingsmæssige kandidater er blevet valideret af vores evne til at tiltrække et ledelsesteam og en investorgruppe, der står så stærkt, til at kommercialisere vores laboratoriers bestræbelser yderligere".

"En ny handlingsmekanisme med dramatisk virkekraft kombineret med en så solid kemi er et fantastisk udgangspunkt til etablering af en ny virksomhed", sagde Giovanni Ferrara, venture-partner hos Novartis Venture Funds. "Kombineret med et team i verdensklasse udgjorde det en overbevisende investering".

I forbindelse med finansieringen blev Peter Bisgaard og Tiba Aynechi fra Novo samt Giovanni Ferrara og Henry Skinner fra Novartis medlem af  virksomhedens bestyrelse sammen med dr. Howard Welgus, tidligere vicepræsident for dermatologisk/inflammatorisk forskning og udvikling hos Pfizer.  

Om Thesan Pharmaceuticals, Inc.

Thesan er en nyligt etableret, venturekapital-finansieret bioteknologisk virksomhed, der er fokuseret på udviklingen og kommercialiseringen af nye lægemidler til behandlingen af dermatologiske lidelser. Besøg www.ThesanPharma.com for yderligere oplysninger

Om Novo Ventures

Novo er holdingselskabet for Novo Group og er helejet af Novo Nordisk Fonden. Den blev stiftet i 1999 til at administrere fondens aktiver og til aktivt at foretage investeringer på fondens vegne. Novo Ventures fokuserer på venturekapital til biovidenskab og er aktiv i både Europa og Nordamerika. Selskabet har fire partnere i København, en i London og tre i San Francisco. Med en udefineret struktur investerer den årligt cirka 100 millioner dollars venturekapital i private biovidenskabelige virksomheder. Besøg www.novo.dk for yderligere oplysninger

Om Novartis Venture Funds

Novar
'/>"/>

SOURCE Thesan Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
2. Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
3. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
4. Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results Webcast And Conference Call To November 2, 2012 Due To Hurricane Sandy
5. Neuraltus Pharmaceuticals Announces Phase 2 Clinical Results for NP001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
7. Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results
8. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
9. Del Mar Pharmaceuticals Expands Collaboration with Guangxi Wuzhou Pharmaceutical Company
10. Webcast Alert: Isis Pharmaceuticals Third Quarter 2012 Financial Results Conference Call
11. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014 MC Medical, a subsidiary of ... Columbus, OH medical device company, have ... laparoscopic and robotic visualization system in Japan ... sale in Japan in the latter ... and an extensive product portfolio in endoscopic surgery market in ...
(Date:8/22/2014)... 22, 2014 Research and Markets ... Chinese Particulate Respirators Industry Report 2014" report to ... Particulate Respirators Industry Report 2014 is a professional and ... particulate respirators industry with a focus on the Chinese ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/22/2014)... August 22, 2014 ... Today Lincor announced general availability of ... that delivers a range of education, entertainment and clinical ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , " ... of care patient engagement to bedside smart devices, " ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Global and Chinese Particulate Respirators Industry Report 2014 2Lincor Unveils Next Generation TV-based Patient Engagement Solution 2
... April 10, 2012 /PRNewswire-Asia/ -- China Botanic Pharmaceutical ... Botanic" or the "Company"), a developer, manufacturer and ... medicines ("TCM") in China, today announced the results ... Meeting") held on Tuesday, April 10, 2012 (Beijing ...
... Mylan Inc. (Nasdaq: MYL ) announced today that ... Thursday, April 26, 2012, at 10:00 a.m. ET, to review ... ended March 31, 2012. Mylan will release its financial results ... dial-in number to access the call is 877.402.3913 or 817.382.5964 ...
Cached Medicine Technology:China Botanic Announces Results of Annual General Meeting 2
(Date:8/22/2014)... Beat Eczema , Susan Clark’s ... natural methods to completely cure the eczema symptoms they ... Shane Michaels, prompting an investigative review. , “Although ... it can still be extremely debilitating and life-altering for ... itching and pain that it causes on the skin ...
(Date:8/22/2014)... the first time an oncogenic somatic mutation at amino ... has been identified in small cell lung cancer (SCLC) ... cell lines produced increased intracellular signaling and cell growth. ... cancer representing 15% of all lung cancers and is ... lung cancer, has been extensively examined for genomic alterations ...
(Date:8/22/2014)... August 22, 2014 Paying tuition and ... in the coming year for four nurse educators pursuing ... National League for Nursing Foundation for Nursing Education . ... share $28,000, $10,000 more than in 2013, thanks to ... Endowment and Elizabeth Isaac Marcil Endowment Funds, both donated ...
(Date:8/22/2014)... New York, New York (PRWEB) August 22, 2014 ... ) continue to be filed in U.S. courts ... cardiovascular events due to their use of prescription ... to court documents, a new claim was filed ... California man who allegedly suffered life-threatening heart issues ...
(Date:8/22/2014)... 2014 CarePoint Health is proud ... Medicine, Geriatrics, Hospice and Palliative Care, Dr. Michelle ... Group. Their system welcomes Dr. Reisner to the ... comprise CarePoint Health Medical Group, a comprehensive network ... representing a wide range of specialties. This latest ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2
... HARRISBURG, Pa. , Jan. 18 Be active to ... Department of Health are conveying to middle school-aged children throughout the ... statewide program kicks off locally at 1:30 p.m. Wednesday, Jan. ... Steelton-Highspire Middle School is an Active Schools grant recipient. ...
... with affect your behavior, for good or bad, research ... you spend time with people who exhibit self-control -- ... instance -- you can expect your own self-control to ... But the opposite seems true, too: Spending time with ...
... KNOXVILLE, Tenn. , Jan. 18 Remote Area Medical®, ... countries and in the U.S., announced today that it will be ... earthquake relief efforts at the Jimani Project facility in Jimani, ... Brock and RAM volunteers loaded more than a ton of ...
... during female ovulation, study finds , MONDAY, Jan. ... a man,s attention shouldn,t wear perfume, new research suggests. ... and Jon K. Maner found that male testosterone levels ... during ovulation, which is when women are most fertile. ...
... Renée ... Health. , ... Heights, N.J. (Vocus) January 18, 2010 -- Renée Schreiber Chervenak, M.D., has recently joined ... Chervenak earned her B.A. summa cum laude at Boston University College of Engineering and ...
... ... osteoporosis everyday because of common misconceptions about the disease. Dr. Karl R.O.S. Johnson, D.C. describes ... osteoporosis - without dangerous medications. , ... (PRWEB) January 18, 2010 -- The National Osteoporosis Foundation in the United States has ...
Cached Medicine News:Health News:Capital BlueCross Partners with Department of Health, Area Schools to Encourage Students to Lead Active, Healthy Lifestyles 2Health News:Capital BlueCross Partners with Department of Health, Area Schools to Encourage Students to Lead Active, Healthy Lifestyles 3Health News:Self-Control Just Might Be Contagious 2Health News:Self-Control Just Might Be Contagious 3Health News:Remote Area Medical Travels to Haiti to Assist in Earthquake Relief Efforts 2Health News:Remote Area Medical Travels to Haiti to Assist in Earthquake Relief Efforts 3Health News:Summit Medical Group Welcomes Rene Schreiber Chervenak, M.D. 2Health News:Medical Breakthrough: Drug Free Strategy Shows Promise for Reversing or Halting Osteoporosis for Michigan Men and Women 2